Not finding it? Sign in to also search OpenAlex live.
-
Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits
Selina Khan, Sonia Marquez-Martinez, Tim Erkens, Adriaan de Wilde, Lea M. M. Costes, Petra Vinken, +8 more
2citations -
Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity2024 Scientific Reports article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 2 patents
Lucy Rutten, Maarten Swart, Annemart Koornneef, Pascale Bouchier, Sven Blokland, Ava Sadi, +16 more
16citations -
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine2021 New England Journal of Medicine article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 14 patents
JERALD C. SADOFF, Mathieu Le Gars, Georgi Shukarev, Dirk Heerwegh, Carla Truyers, Anne Marit de Groot, +20 more
1,216citations
19 results